associated with limited cutaneous scleroderma and CREST syndrome
ANA Comprehensive Panel
This test helps to detect and helps diagnose certain autoimmune disorders, such as lupus and Sjögren syndrome, among other types.
Antinuclear antibodies (ANA) are a group of autoantibodies produced by a person's immune system when it fails to adequately distinguish between "self" and "nonself." The ANA test detects these autoantibodies in the blood.
ANA react with components of the body's own healthy cells and cause signs and symptoms such as tissue and organ inflammation, joint and muscle pain, and fatigue. ANA specifically target substances found in the nucleus of a cell, hence the name "antinuclear." They probably do not damage living cells because they cannot access their nuclei. However, ANA can cause damage to tissue by reacting with nuclear substances when they are released from injured or dying cells.
The ANA test is one of the primary tests for helping to diagnose a suspected autoimmune disorder or rule out other conditions with similar signs and symptoms. The ANA test may be positive with several autoimmune disorders. Patients with the autoimmune disorder systemic lupus erythematosus (SLE) are almost always positive for ANA, but the percentage of patients with other autoimmune disorders who have positive ANA results varies. Also, a significant number of patients with a variety of other types of disorders (and even some heathy people) may be positive for ANA, especially at low levels.
Biomarkers in this category
10 biomarkers · optimal ranges shown
directed against centromere proteins.
primarily associated with lupus
associated with polymyositis and may also be seen in patients with dermatomyositis
a Marker Detection of Lupus Nephropathy
Antibody highly specific for diffuse systemic sclerosis (scleroderma).
marker for systemic lupus erythematosus (SLE)
have been associated with Mixed Connective Tissue disease
Detecting symptoms of a connective tissue disease.
found almost exclusively in people with lupus